Inventor · disambiguated record
Wei Keat Lim
Also filed as: LIM WEI KEAT
4 granted patents·7 pending applications·5 citations·filing 2013–2025
65Inventor score
Top patents by PatentIndex Score
11 records- 0188US12230364B2Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burdenREGENERON PHARMA·Filed 2023·Granted Feb 18, 2025·1 cites·45 claims
- 0283US11640848B2Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burdenREGENERON PHARMA·Filed 2018·Granted May 2, 2023·3 cites·37 claims
- 0376US10325686B2System and methods for integrated and predictive analysis of molecular, imaging, and clinical data for patient-specific management of diseasesMANSI TOMMASO·Filed 2013·Granted Jun 18, 2019·1 cites·11 claims
- 0464US2025118393A1Methods and systems for data down-samplingREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0561US2025218540A1Immunotherapy Methods for Patients Whose Tumors Carry A High Passenger Gene Mutation BurdenREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0657US2023416349A1Methods Of Identifying And Evaluating Cat Allergy Gene Signatures In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0756US2023340601A1Transcriptome Analysis For Treating InflammationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0856US2023349919A1Methods Of Mapping Antigen Specificity To Antibody-Secreting CellsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0953US12157916B2Mitochondrial DNA quality controlREGENERON PHARMA·Filed 2021·Granted Dec 3, 2024·0 cites·19 claims
- 1053US2021142868A1Methods and systems for identifying, classifying, and/or ranking genetic sequencesREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1148US2021090686A1Single cell rna-seq data processingREGENERON PHARMA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Keat Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →